Christian-Peter Luftensteiner

Title: Christian-Peter Luftensteiner: Innovator in Pharmaceutical Technology

Introduction

Christian-Peter Luftensteiner is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of high drug load tablets. His innovative approach has the potential to enhance drug delivery systems and improve patient outcomes.

Latest Patents

Luftensteiner holds a patent for a high drug load tablet. This invention pertains to a tablet that comprises an active ingredient, Compound I, or a pharmaceutically acceptable salt thereof, in an amount ranging from about 30% to 80% by weight of the active moiety based on the total weight of the tablet. This advancement is crucial for optimizing the efficacy of pharmaceutical formulations.

Career Highlights

Christian-Peter Luftensteiner is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in drug formulation and delivery. With a patent portfolio that includes one patent, Luftensteiner continues to push the boundaries of pharmaceutical science.

Collaborations

Some of his notable coworkers include Jean-Claude Bianchi and Joerg Ogorka. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical industry.

Conclusion

Christian-Peter Luftensteiner is a prominent figure in the field of pharmaceutical innovation. His contributions, particularly in high drug load tablet technology, reflect his commitment to improving healthcare solutions. His work at Novartis AG and collaborations with esteemed colleagues further enhance his impact on the industry.